|
1
|
Yuan H, Jin X, Sun J, Li F, Feng Q, Zhang
C, Cao Y and Wang Y: Protective effect of HMGB1 a box on organ
injury of acute pancreatitis in mice. Pancreas. 38:143–148. 2009.
View Article : Google Scholar
|
|
2
|
Felderbauer P, Müller C, Bulut K, Belyaev
O, Schmitz F, Uhl W and Schmidt WE: Pathophysiology and treatment
of acute pancreatitis: new therapeutic targets - a ray of hope?
Basic Clin Pharmacol Toxicol. 97:342–350. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang ZW, Zhang QY, Zhou MT, Liu NX, Chen
TK, Zhu YF and Wu L: Antioxidant inhibits HMGB1 expression and
reduces pancreas injury in rats with severe acute pancreatitis. Dig
Dis Sci. 55:2529–2536. 2010. View Article : Google Scholar
|
|
4
|
Sharif R, Dawra R, Wasiluk K, Phillips P,
Dudeja V, Kurt-Jones E, Finberg R and Saluja A: Impact of toll-like
receptor 4 on the severity of acute pancreatitis and
pancreatitis-associated lung injury in mice. Gut. 58:813–819. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ding SQ, Li Y, Zhou ZG, Wang C, Zhan L and
Zhou B: Toll-like receptor 4-mediated apoptosis of pancreatic cells
in cerulein-induced acute pancreatitis in mice. Hepatobiliary
Pancreat Dis Int. 9:645–650. 2010.PubMed/NCBI
|
|
6
|
Yang Z, Deng Y, Su D, Tian J, Gao Y, He Z
and Wang X: TLR4 as receptor for HMGB1-mediated acute lung injury
after liver ischemia/reperfusion injury. Lab Invest. 93:792–800.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Wang H, Mason JM, Levine J, Yu M,
Ulloa L, Czura CJ, Tracey KJ and Yang H: Recombinant HMGB1 with
cytokine-stimulating activity. J Immunol Methods. 289:211–223.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Andersson U, Erlandsson-Harris H, Yang H
and Tracey KJ: HMGB1 as a DNA-binding cytokine. J Leukoc Biol.
72:1084–1091. 2002.PubMed/NCBI
|
|
9
|
Dumitriu IE, Baruah P, Manfredi AA,
Bianchi ME and Rovere-Querini P: HMGB1: guiding immunity from
within. Trends Immunol. 26:381–387. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang H, Wang H, Czura CJ and Tracey KJ:
HMGB1 as a cytokine and therapeutic target. J Endotoxin Res.
8:469–472. 2002. View Article : Google Scholar
|
|
11
|
Lotze MT, Zeh HJ, Rubartelli A, Sparvero
LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tör M and Billiar
T: The grateful dead: damage-associated molecular pattern molecules
and reduction/oxidation regulate immunity. Immunol Rev. 220:60–81.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim JY, Park JS, Strassheim D, Douglas I,
Diaz del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama
I, et al: HMGB1 contributes to the development of acute lung injury
after hemorrhage. Am J Physiol Lung Cell Mol Physiol.
288:L958–L965. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sawa H, Ueda T, Takeyama Y, Yasuda T,
Shinzeki M, Nakajima T and Kuroda Y: Blockade of high mobility
group box-1 protein attenuates experimental severe acute
pancreatitis. World J Gastroenterol. 12:7666–7670. 2006.PubMed/NCBI
|
|
14
|
Luan ZG, Zhang XJ, Yin XH, Ma XC, Zhang H,
Zhang C and Guo RX: Downregulation of HMGB1 protects against the
development of acute lung injury after severe acute pancreatitis.
Immunobiology. 218:1261–1270. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bianchi ME: DAMPs, PAMPs and alarmins: all
we need to know about danger. J Leukoc Biol. 81:1–5. 2007.
View Article : Google Scholar
|
|
16
|
Kawai T and Akira S: The role of
pattern-recognition receptors in innate immunity: update on
Toll-like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Noreen M, Shah MA, Mall SM, Choudhary S,
Hussain T, Ahmed I, Jalil SF and Raza MI: TLR4 polymorphisms and
disease susceptibility. Inflamm Res. 61:177–188. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wullaert A: Role of NF-kappaB activation
in intestinal immune homeostasis. Int J Med Microbiol. 300:49–56.
2010. View Article : Google Scholar
|
|
19
|
Luo H, Guo P and Zhou Q: Role of
TLR4/NF-κB in damage to intestinal mucosa barrier function and
bacterial translocation in rats exposed to hypoxia. PLoS One.
7:e462912012. View Article : Google Scholar
|
|
20
|
Hori O, Brett J, Slattery T, Cao R, Zhang
J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D, et al: The
receptor for advanced glycation end products (RAGE) is a cellular
binding site for amphoterin. Mediation of neurite outgrowth and
co-expression of rage and amphoterin in the developing nervous
system. J Biol Chem. 270:25752–25761. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park JS, Svetkauskaite D, He Q, Kim JY,
Strassheim D, Ishizaka A and Abraham E: Involvement of Toll-like
receptors 2 and 4 in cellular activation by high mobility group box
1 protein. J Biol Chem. 279:7370–7377. 2004. View Article : Google Scholar
|
|
22
|
Deng Y, Yang Z, Gao Y, Xu H, Zheng B,
Jiang M, Xu J, He Z and Wang X: Toll-like receptor 4 mediates acute
lung injury induced by high mobility group box-1. PLoS One.
8:e643752013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Zhou ZG, Xia QJ, Zhang J, Li HG, Cao
GQ, Wang R, Lu YL and Hu TZ: Toll-like receptor 4 detected in
exocrine pancreas and the change of expression in cerulein-induced
pancreatitis. Pancreas. 30:375–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dawra R, Sharif R, Phillips P, Dudeja V,
Dhaulakhandi D and Saluja AK: Development of a new mouse model of
acute pancreatitis induced by administration of L-arginine. Am J
Physiol Gastrointest Liver Physiol. 292:G1009–G1018. 2007.
View Article : Google Scholar
|
|
25
|
Schmidt J, Lewandrowsi K, Warshaw AL,
Compton CC and Rattner DW: Morphometric characteristics and
homogeneity of a new model of acute pancreatitis in the rat. Int J
Pancreatol. 12:41–51. 1992.PubMed/NCBI
|
|
26
|
Pozsar J, Berger Z, Simon K, Kovacsai A,
Marosi E and Pap A: Biphasic effect of prostaglandin E1 on the
severity of acute pancreatitis induced by a closed duodenal loop in
rats. Pancreas. 12:159–164. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Guo W, Li Y, Pan X, Lv W, Cui L,
Li C, Wang Y, Yan S, Zhang J and Liu B: Hypothermia induced by
adenosine 5′-mono-phosphate attenuates injury in an
L-arginine-induced acute pancreatitis rat model. J Gastroenterol
Hepatol. 29:742–748. 2014. View Article : Google Scholar
|
|
28
|
Jamdar S, Babu BI, Nirmalan M, Jeziorska
M, McMahon RF and Siriwardena AK: Administration of human
recombinant activated protein C is not associated with pancreatic
parenchymal haemorrhage in L-arginine-induced experimental acute
pancreatitis. JOP. 14:610–617. 2013.PubMed/NCBI
|
|
29
|
Yenicerioglu A, Cetinkaya Z, Girgin M,
Ustundag B, Ozercan IH, Ayten R and Kanat BH: Effects of
trimetazidine in acute pancreatitis induced by L-arginine. Can J
Surg. 56:175–179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chung KY, Park JJ and Kim YS: The role of
high-mobility group box-1 in renal ischemia and reperfusion injury
and the effect of ethyl pyruvate. Transplant Proc. 40:2136–2138.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang H, Ochani M, Li J, Qiang X, Tanovic
M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, et al:
Reversing established sepsis with antagonists of endogenous
high-mobility group box 1. Proc Natl Acad Sci USA. 101:296–301.
2004. View Article : Google Scholar :
|
|
32
|
Kokkola R, Li J, Sundberg E, Aveberger AC,
Palmblad K, Yang H, Tracey KJ, Andersson U and Harris HE:
Successful treatment of collagen-induced arthritis in mice and rats
by targeting extracellular high mobility group box chromosomal
protein 1 activity. Arthritis Rheum. 48:2052–2058. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Andrassy M, Volz HC, Igwe JC, Funke B,
Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK,
et al: High-mobility group box-1 in ischemia-reperfusion injury of
the heart. Circulation. 117:3216–3226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kong X, Yuan H, Wu X, Zhang J, Zhou H,
Wang M, Liu Y and Jin X: High-mobility-group box protein 1A box
reduces development of sodium laurate-induced thromboangiitis
obliterans in rats. J Vasc Surg. 57:194–204. 2013. View Article : Google Scholar
|
|
35
|
Kohno T, Anzai T, Kaneko H, Sugano Y,
Shimizu H, Shimoda M, Miyasho T, Okamoto M, Yokota H, Yamada S, et
al: High-mobility group box 1 protein blockade suppresses
development of abdominal aortic aneurysm. J Cardiol. 59:299–306.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ueno H, Matsuda T, Hashimoto S, Amaya F,
Kitamura Y, Tanaka M, Kobayashi A, Maruyama I, Yamada S, Hasegawa
N, et al: Contributions of high mobility group box protein in
experimental and clinical acute lung injury. Am J Respir Crit Care
Med. 170:1310–1316. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kang R, Zhang Q, Hou W, Yan Z, Chen R,
Bonaroti J, Bansal P, Billiar TR, Tsung A, Wang Q, et al:
Intracellular Hmgb1 inhibits inflammatory nucleosome release and
limits acute pancreatitis in mice. Gastroenterology. 146:1097–1107.
2014. View Article : Google Scholar :
|
|
38
|
Lange SS, Mitchell DL and Vasquez KM: High
mobility group protein B1 enhances DNA repair and chromatin
modification after DNA damage. Proc Natl Acad Sci USA.
105:10320–10325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kawase T, Sato K, Ueda T and Yoshida M:
Distinct domains in HMGB1 are involved in specific intramolecular
and nucleosomal interactions. Biochemistry. 47:13991–13996. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cato L, Stott K, Watson M and Thomas JO:
The interaction of HMGB1 and linker histones occurs through their
acidic and basic tails. J Mol Biol. 384:1262–1272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Giavara S, Kosmidou E, Hande MP, Bianchi
ME, Morgan A, d'Adda di Fagagna F and Jackson SP: Yeast Nhp6A/B and
mammalian Hmgb1 facilitate the maintenance of genome stability.
Curr Biol. 15:68–72. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Celona B, Weiner A, Di Felice F, Mancuso
FM, Cesarini E, Rossi RL, Gregory L, Baban D, Rossetti G, Grianti
P, et al: Substantial histone reduction modulates genomewide
nucleosomal occupancy and global transcriptional output. PLoS Biol.
9:e10010862011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bonaldi T, Längst G, Strohner R, Becker PB
and Bianchi ME: The DNA chaperone HMGB1 facilitates
ACF/CHRAC-dependent nucleosome sliding. EMBO J. 21:6865–6873. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Covert MW, Leung TH, Gaston JE and
Baltimore D: Achieving stability of lipopolysaccharide-induced
NF-kappaB activation. Science. 309:1854–1857. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang H, Hreggvidsdottir HS, Palmblad K,
Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y,
et al: A critical cysteine is required for HMGB1 binding to
Toll-like receptor 4 and activation of macrophage cytokine release.
Proc Natl Acad Sci USA. 107:11942–11947. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dobrovolskaia MA, Medvedev AE, Thomas KE,
Cuesta N, Toshchakov V, Ren T, Cody MJ, Michalek SM, Rice NR and
Vogel SN: Induction of in vitro reprogramming by Toll-like receptor
(TLR)2 and TLR4 agonists in murine macrophages: effects of TLR
'homotolerance' versus 'heterotolerance' on NF-kappa B signaling
pathway components. J Immunol. 170:508–519. 2003. View Article : Google Scholar
|
